Colorectal cell kinetics

British Journal of Surgery

Volumn 83, Issue 6, 1996, Pages 739-749

  Gilliland, R ^a   Williamson, K E ^a   Wilson, R H ^a   Anderson, N H ^a   Hamilton, P W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORADIOGRAPHY; CELL CYCLE S PHASE; CELL KINETICS; CELL PROLIFERATION; COLORECTAL CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METAPHASE; METHODOLOGY; MITOSIS INDEX; PLOIDY; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; CELL CYCLE; CELL DIVISION; COLON; HUMANS; KI-67 ANTIGEN; MITOTIC INDEX; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PLOIDIES; PROLIFERATING CELL NUCLEAR ANTIGEN; RECTUM; S PHASE; THYMIDINE;

EID: 0030027495     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830607     Document Type: Review

References (181)

1. van der Werf SDJ. Epidemiology and aetiology of large bowel carcinoma. Neth J Med 1983; 26: 240-6.
2. Ziegler RG, Devesa SS, Fraumeni JF Jr. Epidemiologic patterns of colorectal cancer. Important Adv Oncol 1986; 209-32.
3. Kee F, Collins BJ, Patterson CC. Incidence and site distribution of colorectal cancer in Northern Ireland. Ulster Med J 1990; 59: 155-60.
4. Barker DJP, Godfrey KM. Geographical variations in the incidence of colorectal cancer in Britain. Br J Cancer 1984; 50: 693-8.
5. Kee F, Wilson RH, Gilliland R, Sloan JM, Rowlands BJ, Moorehead RJ. Changing site distribution of colorectal cancer. BMJ 1992; 305: 158.
6. Gloeckler Ries LA, Edwards BK, Sondik EJ. Trends in colorectal cancer incidence - United States, 1973-1986. MMWR Morb Mortal Wkly Rep 1989; 38: 728-31.
7. Ayiomamitis A. The epidemiology of malignant neoplasms of the large intestine in Canada: 1941-1985. J Clin Gastroenterol 1989; 11: 38-42.
8. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-32.
9. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-52.
10. Kirklin JW, Dockerty MB, Waugh JM. The role of the peritoneal reflection in the prognosis of carcinomas of the rectum and sigmoid-colon. Surg Gynecol Obstet 1949; 88: 326-31.
11. Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967; 166: 420-7.
12. Jass JR, Love SB, Northover JMA. A new prognostic classification for rectal cancer. Lancet 1987; i: 1303-6.
13. Wood CB, Gillis CR, Hole D, Malcolm AJH, Blumgart LH. Local tumour invasion as a prognostic factor in colorectal cancer. Br J Surg 1981; 68: 326-8.
14. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging. Arch Intern Med 1975; 135: 1441-53.
15. Deans GT, Heatley M, Anderson N et al. Jass' classification revisited. J Am Coll Surg 1994; 179: 11-17.
16. 32 as demonstrated by autoradiographs. Exp Cell Res 1951; 2: 178-87.
17. Baserga R. The cell cycle. N Engl J Med 1981; 304: 453-9.
18. Leblond CP. Classification of cell populations on the basis of their proliferative behavior. Nat Cancer Inst Monogr 1964; 14: 119-50.
19. Lajtha LG. On the concept of the cell cycle. J Cell Comp Physiol 1963; 62(Suppl I): 143-5.
20. Steel GG. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer 1967; 3: 381-7.
21. Mendelsohn ML. The growth fraction: a new concept applied to tumors. Science 1960; 132: 1496 (Abstract).
22. 1 events and regulation of cell proliferation. Science 1989; 246: 603-8.
23. Evan GI. The molecular basis of mammalian cell growth control. In: Jacquemin-Sablon A, ed. Flow Cytometry. New Developments. Berlin; Springer, 1993; 277-90.
24. Bresciani F, Paoluzi R, Benassi M, Nervi C, Casale C, Ziparo E. Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res 1974; 34: 2405-15.
25. Trotter GA, Morgan GR, Cooper AJ, Kirkham N, Whitehouse JMA, Taylor I. Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy. Gut 1985; 26: 267-73.
26. Kamel OW, Franklin WA, Ringus JC, Meyer JS. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 1989; 134: 107-13.
27. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223-35.
28. Hoshino T, Nagashima T, Cho KG et al. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. Int J Cancer 1986; 38: 369-74.
29. Fowler JF. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate he used? Int J Radiat Oncol Biol Phys 1986; 12: 641-5.
30. Wilson GD, McNally NJ, Dische S, Bennett MH. Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine. Br J Radiol 1988; 61: 419-22.
31. Latt SA. Fluorescent prohes of DNA microstructure and synthesis. In: Melamed MR, Mullaney RF, Mendelsohn ML, eds. Flow Cytometry and Sorting. New York: John Wiley, 1979: 263-84.
32. Melamed MR, Mullaney PF. An historical review of the development of flow cytometers and sorters. In: Melamed MR, Mullaney PF, Mendelsohn ML, eds. Flow Cytometry and Sorting. 2nd ed. New York: John Wiley. 1990: 1-9.
33. Wyllie AH. The flow cytometer. BMJ 1987; 294: 139 (Editorial).
34. Watson JV. Flow cytometry in biomedical science. Nature 1987; 325: 741-2.
35. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-5.
36. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985; 6: 327-33.
37. Barlogie B, Raber MN, Schumann J et al. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982-97.
38. Merkel DE, Dressler LG, McGuire WL. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol 1987; 5: 1690-703.
39. Mauro F, Teodori L, Schumann J, Göhde W. Flow cytometry as a tool for the prognostic assessment of human neoplasia. Int J Radiat Oncol Biol Phys 1986; 12: 625-36.
40. Frankfurt OS, Arbuck SG, Chin JL et al. Prognostic applications of DNA flow cytometry for human solid tumors. Ann NY Acad Sci 1986; 468: 276-90.
41. Hiddemann W, Schumann J, Andreeff M et al. Convention on nomenclature for DNA cytometry. Cytoetry 1984; 5: 445-6.
42. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 1986; 10: 229-41.
43. Dean PN, Jett JH. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974; 60: 523-7.
44. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW. Cell-cycle analysis using a monoclonal antibody to BrdUrd. Cell Tissue Kinet 1984; 17: 427-36.
45. Rew DA. Significance of aneuploidy. Br J Surg 1994; 81: 1416-22.
46. Lloveras B, Garin-Chesa P, Myc A, Melamed M. In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis. Am J Clin Pathol 1994; 101: 703-7.
47. Ouirke P, Dyson JED, Dixon MF, Bird CC, Joslin CAF. Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer 1985; 51: 99-106.
48. Lindmark G, Glimelius B, Påhlman L, Enblad P. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis 1991; 6: 115-20.
49. Baretton G, Gille J, Ocvermann E, Löhrs U. Flow-cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchows Arch B Cell Pathol 1991; 60: 123-31.
50. Kim YJ, Ngoi SS, Godwin TA, DeCosse JJ, Staiano-Coico L. Ploidy in invasive colorectal cancer. Implications for metastatic disease. Cancer 1991; 68: 638-41.
51. Taniyama K, Suzuki H, Matsumoto M, Hakamada K, Toyama K, Tahara E. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum. Jpn J Clin Oncol 1991; 21: 406-11.
52. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 1982; 69: 15-22.
53. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72: 828-30.
54. Bosari S, Lee AK, Wiley BD, Heatley GJ, Silverman ML. Flow cytometric and image analyses of colorectal adenocarcinomas. A comparative study with clinical correlations. Am J Clin Pathol 1993; 99: 187-94.
55. Cavaliere F, Guadagni F, D'Agnano I et al. Biologic and clinical correlations among ploidy, cell kinetics, and the tumour-associated glycoprotein-72 tissue expression in colorectal cancer. Preliminary findings. Dis Colon Rectum 1994; 37(2 Suppl): S24-9.
56. Costa A, Faranda A, Scalmati A et al. Autoradiographic and flow-cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinicopathological features. Int J Cancer 1992; 50: 719-23.
57. Deans GT, Williamson K, Heatley M et al. The role of flow cytometry in carcinoma of the colon and rectum. Surg Gynecol Obstet 1993; 177: 377-82.
58. Enker WE, Kimmel M, Cibas ES, Cranor ML. Melamed MR. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 1991; 83: 701-7.
59. Fausel RF, Burleigh W, Kaminsky DB. DNA quantification in colorectal carcinoma using flow and image analysis cytometry. Anal Quant Cytol Histol 1990; 12: 21-7.
60. Giaretti W, Danova M, Geido E et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991; 67: 1921-7.
61. Goh HS, Jass JR, Atkin WS, Cuzick J, Northover JMA. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int J Colorectal Dis 1987; 2: 17-21.
62. Heimann TM, Oh SC, Martinelli G et al. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indications. Am J Surg 1992; 164: 13-17.
63. Hiddemann W, von Bassewitz, DB, Kleinemeier H-J et al. DNA stemline heterogeneity in colorectal cancer. Cancer 1986; 58: 258-63.
64. Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988; 75: 28-33.
65. Kouri M. DNA ploidy of colorectal carcinoma by tumour site, gender and history of noncolorectal malignancies. Oncology 1993; 50: 41-5.
66. Lanza G Jr, Maestri I, Ballotta MR, Dubini A, Cavazzini L. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer. Mod Pathol 1994; 7: 161-5.
67. Meling GI, Rognum TO, Clausen OP et al. Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study? Cancer 1991; 67: 1642-9.
68. Quirke P, Dixon MF, Clayden AD et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987; 151: 285-91.
69. Rognum TO, Thorud F, Elgjo K, Brandtzaeg P, Ørjasacter H, Nygaard K. Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. Br J Cancer 1982; 45: 921-34.
70. Schillaci A, Tirindelli DD, Ferri M et al. Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis 1990; 5: 223-7.
71. Schutte A, Reynders MMJ, Wiggers G et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987; 47: 5494-6.
72. Scott NA, Rainwater LM, Wieand HS et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987; 30: 513-20.
73. Silvestrini R, D'Agnano I, Faranda A et al. Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 1993; 67: 1042-6.
74. Stipa S, Danesi DT, Modini C et al. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry. Surg Gynecol Obstet 1993; 176: 427-34.
75. Tomoda H, Kakeji Y, Furusawa M. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study. J Surg Oncol 1993; 53: 144-8.
76. Perrin-Cottier M, Jouffre C, Sabido O et al. Flow cytometric analysis of DNA content in colorectal polyps resected at endoscopy. Anal Quant Cytol Histol 1991; 13: 132-8.
77. Goh HS. Flow cytometry and colorectal neoplasia. Ann Acad Med Singapore 1987; 16: 535-8.
78. Sciallero S, Bruno S, Di Vinci A, Geido E, Aste H, Giaretti W. Flow cytometric DNA ploidy in colorectal adenomas and family history of colorectal cancer. Cancer 1988; 61: 114-20.
79. Hall PA, Levison DA. Review: Assessment of cell proliferation in histological material. J Clin Pathol 1990; 43: 184-92.
80. Baak JPA, van Dop H, Kurver PHJ, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985; 56: 374-82.
81. Aherne WA, Camplejohn RS, Al-Wiswasy M, Ford D, Kellerer AM. Assessment of inherent fluctuations of mitotic and labelling indices of human tumours. Br J Cancer 1977; 36: 577-82.
82. Ota DM, Drewinko B,. Growth kinetics of human colorectal carcinoma. Cancer Res 1985; 45: 2128-31.
83. Veronese S, Gambacorta M, Falini B. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody. J Clin Pathol 1989; 42: 820-6.
84. Khan S, Raza A, Petrelli N, Mittleman A. In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonie mucosa using intravenous infusions of bromodeoxyuridine. J Surg Oncol 1988; 39: 114-18.
85. Hamilton E, Dobbin J. The validity of the labelling index in tumour studies. Br J Cancer 1985; 51: 15-21.
86. Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 1989; 15: 1-18.
87. Taylor JH, Woods PS, Hughes WL. The organization and duplication of chromosomes as revealed by autoradiographic studies using tritium-labeled thymidine. Proc Natl Acad Sci USA 1957; 43: 122-8.
88. Meyer JS. Cell kinetic measurements of human tumors. Hum Pathol 1982; 13: 874-7.
89. Lipkin M, Sherlock P, Bell B. Cell proliferation kinetics in the gastrointestinal tract of man. II. Cell renewal in stomach, ileum, colon and rectum. Gastroenterology 1963; 45: 721-9.
90. 3. Gastroenterology 1961; 41: 122-5.
91. 3 thymidine incorporation in mucosa of multiple polyposis. J Clin Invest 1963; 42: 1922-8.
92. Cole JW, McKalen A. Studies on the morphogenesis of adenomatous polyps in the human colon. Cancer 1963; 16: 998-1002.
93. Deschner EE, Winawer SJ, Long FC, Boyle CC. Early detection of colonic neoplasia in patients at high risk. Cancer 1977; 40(5 Suppl): 2625-31.
94. Bleiberg H, Buyse M, Galand P. Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer 1985; 56: 124-9.
95. Deschner EE. Adenomas. Preneoplastic events, growth and development in man and experimental systems. Pathol Annu 1983; 18: 205-19.
96. Deschner EE, Raicht RF. Kinetic and morphologic alterations in the colon of a patient with multiple polyposis. Cancer 1981; 47: 2440-5.
97. Bleiberg H, Galand P. In vitro autoradiographic determination of cell kinetic parameters in adenocarcinomas and adjacent healthy mucosa of the human colon and rectum. Cancer Res 1976; 36: 325-8.
98. Lipkin M, Blattner WE, Fraumeni JF Jr, Lynch HT, Deschner EE, Winawer S. Tritiated thymidine (phi p. phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983; 43: 1899-904.
99. Deschner EE. Early proliferative changes in gastrointestinal neoplasia. Am J Gastroenterol 1982; 77: 207-11.
100. Maskens AP, Deschner EE. Tritiated thymidine incorporation into epithelial cells of normal-appearing colorectal mucosa of cancer patients. J Natl Cancer Inst 1977; 58: 1221-4.
101. Scalmati A, Ronucci L, Ghidini G, Biasco G, Ponz de Leon M. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res 1990; 50: 7937-41.
102. Lieb LM, Lisco H. In vitro uptake of tritiated thymidine by carcinoma of the human colon. Cancer Res 1966; 26: 733-40.
103. Meyer JS, Prioleau PG. S-phase fractions of colorectal carcinomas related to pathologic and clinical features. Cancer 1981; 48: 1221-8.
104. 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers. Mod Pathol 1991; 4: 627-31.
105. Wolberg WH, Ansfield FJ. The relation of thymidine labeling index in human tumors in vitro to the effectiveness of 5-fluorouracil chemotherapy. Cancer Res 1971; 31: 448-50.
106. Raza A, Preisler HD, Mayers GL, Bankert R. Rapid enumeration of S-phase cells by means of monoclonal antibodies. N Engl J Med 1984; 310: 991 (Letter).
107. Vanderlaan M, Thomas CB. Characterization of monoclonal antibodies to bromodeoxyuridine. Cytometry 1985; 6: 501-5.
108. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218: 474-5.
109. Morstyn G, Hsu SM, Kinsella T, Gratzner H, Russo A, Mitchell JB. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 1983; 72: 1844-50.
110. Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 1985; 6: 627-32.
111. Qin Y, Willems G. Comparison of the classical autoradiographic and the immunohistochemical methods with BrdU for measuring proliferation parameters in colon cancer. Anticancer Res 1993; 13: 731-6.
112. Wynford-Thomas D, Williams ED. Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 1986; 19: 179-82.
113. Dunova M, Wilson G, Riccardi A et al. In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies. Haematologica 1987; 72: 115-19.
114. Hoshino T, Nagashima T, Murovic JA, Wilson CB. Davis RL. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 1986; 58: 1466-72.
115. Kinsella TJ, Mitchell JB, Russo A et al. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer. J Clin Oncol 1984; 2: 1144-50.
116. Rew DA, Wilson GD Taylor I, Weaver PC. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg 1991; 78: 60-6.
117. Roncucci L, Pedroni M, Scalmati A et al. Cell kinetic evaluation of human colorectal tumors after in vivo administration of bromodeoxyuridine. Int J Cancer 1992; 52: 856-61.
118. Rozen P. An evaluation of rectal epithelial proliferation measurement as biomarker of risk for colorectal neoplasia and response in intervention studies. Eur J Cancer Prev 1992; 1: 215-24.
119. Morstyn O, Pyke K, Gardner J, Ashcroft R, de Fazio A, Bhathal P. Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody. J Histochem Cytochem 1986; 34: 697-701.
120. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A 1983; 80: 5573-7.
121. Gonchoroff NJ, Katzmann JA, Currie RM et al. S-phase detection with an antibody to bromodeoxyuridine. Role of DNAse pretreatment. J Immunol Methods 1986; 93: 97-101.
122. Williamson K, Gilliland R, Weir H et al. Hydrochloric acid denaturation of colorectal tumour tissue infiltrated with bromodeoxyuridine. Cytometry 1994; 15: 162-8.
123. Gonchoroff NJ, Greipp PR, Kyle RA, Katzmann JA. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation. Cytometry 1985; 6: 506-12.
124. Risio M, Coverlizza S, Ferrari A, Candelaresi GL, Rossini FP. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology 1988; 94: 899-906.
125. Potten CS, Kellett M, Rew DA, Roberts SA. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and a polyposis coli. Gut 1992; 33: 524-9.
126. Risio M, Candelaresi G, Rossini FP. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence. Cancer Epidemiol Biomarkers Prev 1993; 2: 363-7.
127. Wilson RG, Smith AN, Bird CC. Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps. J Clin Pathol 1990; 43: 744-7.
128. Risio M, Lipkin M, Candelaresi GL, Bertone A, Coverlizza S, Rossini FP. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991; 51: 1917-21.
129. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
130. Gerdes J, Lemke II, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-15.
131. Neubauer A, Huhn D. Monoclonal antibody Ki-67 as a proliferation marker. Br J Haematol 1987; 67: 495 (Letter).
132. Walker RA, Camplejohn RS. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 1988; 57: 281-3.
133. Cattoretti G, Becker MHG. Key G et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63.
134. Shepherd NA, Richman PI, England J. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol 1988; 155: 213-19.
135. Berenzi A, Benetti A, Bertalot G et al. Ki-67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications. Pathologica 1992; 84: 155-63.
136. Benetti A, Berenzi A, Grigolato P. Growth fraction of colorectal carcinoma (Ki67): a comparative study. Im J Biol Markers 1992; 7: 93-6.
137. Horny U-P, Horst H-A. Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67. Zentralbl Allg Pathol 1988; 134: 547-54.
138. Johnston PG, O'Brien MJ, Dervan PA, Carney DN. Immunohistochemical analysis of cell kinetic parameters in colonie adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 1989; 20: 696-700.
139. Sahin AA, Ro YJ, Brown RW et al. Assessment of Ki-67 derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol 1994; 7: 17-22.
140. Linden MD, Ma CK, Kubus J, Brown RD, Zarbo RJ. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993; 100: 206-12.
141. Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 1992; 70: 2602-9.
142. Suzuki H, Matsumoto K, Terabe M. Ki-67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol 1992; 15: 317-20.
143. Lanza O Jr, Cavazzini L, Borghi L, Ferretti S, Buccoliero F, Rubbini M. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables. Pathol Res Pract 1990; 186: 608-18.
144. Risio M, Rossini FP. Cell proliferation in colorectal adenomas containing invasive carcinoma. Anticancer Res 1993; 13: 43-7.
145. Diebold J, Lai MD, Löhrs U. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material. Virchows Arch B Cell Pathol 1992; 62: 283-9.
146. Sasaki K, Matsumura K, Tsuji T, Shinozaki F, Takahashi M. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 1988; 62: 989-93.
147. 2)-phase fractions determined by flow cytometry and Ki-67 labelling indices in colorectal carcinomas. Oncology 1994; 51: 9-12.
148. Bravo R, Celis JE. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol 1980; 84: 795-802.
149. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-17.
150. Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985; 82: 3262-6.
151. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981; 154: 1899-909.
152. Celis JE, Bravo R, Larsen PM, Fey SJ. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 1984; 8: 143-57.
153. Roos G, Landberg G, Huff JP, Houghten R, Takasaki Y, Tan EM. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab Invest 1993; 68: 204-10.
154. Hall PA, Levison DA, Woods AL et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285-94.
155. Gratzner HG, Leif RC. An immunofluorescence method for monitoring DNA synthesis by flow cytometry. Cytometry 1981; 1: 385-93.
156. Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 1991; 51: 4570-4.
157. van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJH, Cornelisse CJ. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol 1991; 138: 1165-72.
158. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using antigen PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 1989; 134: 733-9.
159. Galand P, Degraef C. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989; 22: 383-92.
160. al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993; 71: 1954-9.
161. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 1994; 73: 575-9.
162. Mayer A, Takimoto M, Fritz E. Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993; 71: 2454-60.
163. Wahl AF, Geis AM, Spain BH, Wong SW, Korn D, Wang TSF. Gene expression of human DNA polymerase alpha during cell proliferation and the cell cycle. Mol Cell Biol 1989; 8: 5016-25.
164. Tanaka S, Hu S-Z, Wang TSF, Korn D. Preparation and preliminary characterization of monoclonal antibodies against human DNA polymerase alpha. J Biol Chem 1982; 257: 8386-90.
165. Bensch KG, Tanaka S, Hu S-Z, Wang TSF, Korn D. Intracellular localization of human DNA polymerase alpha with monoclonal antibodies. J Biol Chem 1982; 257: 8391-6.
166. Steel GG. Growth Kinetics of Tumours: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer. Oxford: Clarendon Press, 1977.
167. Taylor JMG, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990; 17: 95-102.
168. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonagen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
169. Bolin S, Nilsson E, Sjödahl R. Carcinoma of the colon and rectum - growth rate. Ann Surg 1983; 198: 151-8.
170. Welin S, Youker J, Spratt JS Jr et al. The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmö technique). AJR Am J Roentgenol 1963; 90: 673-87.
171. Ekelund G, Lindström C, Rosengren JE. Appearance and growth of early carcinomas of the colon-rectum. Acta Radial [Diagn] (Stockh) 1974; 15: 670-9.
172. Burnett KR, Greenbaum EI. Rapidly growing carcinoma of the colon. Dis Colon Rectum 1981; 24: 282-6.
173. Figiel LS, Figiel SJ, Wietersen FK. Roentgenologic observations of growth rates of colonie polyps and carcinoma. Acta Radiol [Diagn] (Stockh) 1965; 3: 417-29.
174. Quastler H, Sherman FG. Cell population kinetics in the intestinal epithelium of the mouse. Exp Cell Res 1959; 17: 420-38.
175. Terz JJ, Curutchet HP, Lawrence W Jr. Analysis of the cell kinetics of human solid tumors. Cancer 1971; 28: 1100-10.
176. Lipkin M. Cell Cycle and Cancer. New York: Decker, 1971: 1-26.
177. Camplejohn RS, Bone G, Aherne W. Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic study. Eur J Cancer 1973; 9: 577-81.
178. Wright NA, Appleton DR. The metaphase arrest technique. A critical review. Cell Tissue Kinet 1980; 13: 643-63.
179. Begg AC, McNally NJ, Shrieve DC, Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620-6.
180. Wilson MS, West CM, Wilson GD, Roberts SA, James RD, Schofield PF. Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer 1993; 68: 501-6.
181. Gilliland R, Williamson KE, Hamilton PW. Crockard A, Rowlands BJ, Spence RAJ. Invalidation of bromodeoxyuridinc flow cytometric analysis of colorectal tumours by flawed methodology. Br J Surg 1994; 81: 748 (Abstract).